BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zeng MH, Shi QY, Xu L, Mi YQ. Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease. World J Gastroenterol 2024; 30(10): 1393-1404 [PMID: 38596499 DOI: 10.3748/wjg.v30.i10.1393]
URL: https://www.wjgnet.com/1007-9327/full/v30/i10/1393.htm
Number Citing Articles
1
Hao Lv, Yang Liu. Management of non-alcoholic fatty liver disease: Lifestyle changesWorld Journal of Gastroenterology 2024; 30(22): 2829-2833 doi: 10.3748/wjg.v30.i22.2829
2
Raffaele Borriello, Giorgio Esposto, Irene Mignini, Antonio Gasbarrini, Maria Assunta Zocco. Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical needWorld Journal of Gastroenterology 2024; 30(25): 3143-3146 doi: 10.3748/wjg.v30.i25.3143
3
Wei Zhu. Effective roles of exercise and diet adherence in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2024; 30(29): 3456-3460 doi: 10.3748/wjg.v30.i29.3456
4
Eunbyul Cho, Sunwoo Kim, Soonkyu Kim, Ju Young Kim, Hwa Jung Kim, Yumi Go, Yu Jung Lee, Haesol Lee, Siye Gil, Sung Kwon Yoon, Keonho Chu. The Effect of Mobile Lifestyle Intervention Combined with High-Protein Meal Replacement on Liver Function in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Controlled TrialNutrients 2024; 16(14) doi: 10.3390/nu16142254
5
Vadim A. Akhmedov, Maria A. Livzan. Patient compliance with NAFLD: what can we do to improve it? A reviewConsilium Medicum 2025; 27(5) doi: 10.26442/20751753.2025.5.203264
6
Yusuf Yilmaz. Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesisFrontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1615809
7
Cen-Qin Liu, Bing Hu. Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2024; 30(25): 3179-3181 doi: 10.3748/wjg.v30.i25.3179
8
Chieh Liu, Chun-Jen Liu. Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver DiseaseJournal of Obesity & Metabolic Syndrome 2025; 34(3) doi: 10.7570/jomes25028
9
Xue Han, Yuchen Fang, Huanyu Wang, Anni Fu, Jianfeng Sun, Zhiqiang Wang, Lei Ma. The hawthorn (Crataegus pinnatifida) procyanidin extract attenuates nonalcoholic fatty liver disease in mice via remodeling the bile acid profile driven by gut microbiota and regulating the FXR pathwayFood & Function 2026; 17(13) doi: 10.1039/D6FO01304J
10
Wafaa Mohamed Ezzat. Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2024; 30(20): 2633-2637 doi: 10.3748/wjg.v30.i20.2633
11
Meer M Chisthi. Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2024; 30(20): 2629-2632 doi: 10.3748/wjg.v30.i20.2629
12
Valentina Pecoraro, Fabio Nascimbeni, Filippo Gabrielli, Tommaso Fasano, Tommaso Trenti. Direct serum biomarkers of liver fibrosis in metabolic dysfunction-associated steatotic liver disease: A scoping reviewClinical Biochemistry 2026; 144 doi: 10.1016/j.clinbiochem.2026.111138